Voyager Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -28.6% | -38.0% | -19.6% | -2.5% | +452.7% | -85.2% | +173.4% | -18.7% | -4.1% | +158.8% | +786.8% | -55.7% | +59.9% | -44.7% | +58.7% | +310.9% | -94.5% | -0.6% | -79.1% | +9.2% | +1,794.3% | -97.7% | +8.2% | +5,670.5% | -103.8% | – | -96.8% | -4.9% | +1,851.9% | -78.3% | +51.6% | -16.7% | -74.5% | +3.1% | -19.7% | +157.0% | +14.7% | -83.1% | +22.1% | – | |
| – | +23.4% | +10.6% | +8.7% | +27.8% | -31.9% | +11.5% | +11.1% | +0.8% | +1.7% | +46.8% | +2.0% | +17.6% | +22.7% | -11.6% | -8.9% | -14.9% | -12.2% | +1.6% | -12.7% | -8.2% | -21.7% | +2.3% | -12.7% | +54.4% | -24.8% | +27.6% | +18.4% | +17.6% | -94.8% | -10.4% | +2,571.6% | -5.4% | +8.5% | -3.9% | -0.6% | +14.5% | -6.5% | -97.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -145.0% | – | – | – | – | -116.7% | – | – | – | – | -197.4% | – | – | -174.0% | – | -113.0% | – | – | -79.4% | -113.0% | – | – | – | – | – | – | – | +90.5% | – | |
| – | +23.4% | +10.6% | +8.7% | +27.8% | -31.9% | +11.5% | +11.1% | +0.8% | +1.7% | +46.8% | +15.1% | +4.2% | +22.7% | -11.6% | -8.9% | -14.9% | -12.2% | +1.6% | -12.7% | -8.2% | -21.7% | +2.3% | -12.7% | +54.4% | -24.8% | +27.6% | +18.4% | +17.6% | -5.6% | +6.0% | +33.0% | -12.2% | +17.7% | -11.4% | -0.6% | +14.5% | +0.2% | -31.6% | -10.4% | – | |
| – | +3.3% | +41.2% | -8.1% | +9.4% | +8.6% | +33.8% | +63.8% | -43.8% | +24.9% | +17.0% | -13.8% | +1.7% | +16.9% | +3.2% | -19.3% | +0.5% | -0.1% | +17.8% | +7.1% | -16.5% | -4.2% | -8.3% | -1.4% | -3.2% | +15.8% | +6.7% | -8.1% | -0.4% | +24.0% | -16.0% | +17.9% | -19.5% | +10.1% | +7.2% | +8.9% | -22.9% | +1.5% | +0.5% | -9.0% | – | |
| – | +18.5% | +17.2% | +4.4% | +23.7% | -23.7% | +17.9% | +28.3% | -17.8% | +8.3% | +37.0% | +7.0% | +3.6% | -74.1% | +3.2% | -19.3% | +0.5% | -0.1% | +17.8% | +7.1% | -16.5% | -4.2% | -8.3% | -1.4% | -3.2% | +15.8% | +6.7% | -8.1% | -0.4% | +319.8% | -0.5% | -63.3% | -35.4% | +44.1% | -18.1% | +8.9% | -22.9% | +44.8% | +172.5% | -7.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -293.8% | – | – | – | – | -128.1% | – | – | – | – | -474.4% | – | – | -270.1% | – | -120.7% | – | – | -129.9% | – | – | – | – | – | – | – | – | – | – | |
| – | -16.7% | -74.1% | +0.8% | +14.1% | -100.0% | – | +48.0% | +8.3% | -100.0% | – | +83.1% | -13.1% | – | – | -64.6% | -26.6% | -68.1% | -76.5% | +152.6% | +152.1% | +431.4% | -95.2% | +606.5% | +148.9% | +82.9% | +194.8% | +11.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -234.5% | – | – | – | – | -118.6% | – | – | – | – | -473.4% | – | – | -234.0% | – | -117.8% | – | – | -119.8% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -163.7% | – | -348.7% | – | -680.6% | – | -2,645.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +4,300.0% | -91.6% | +200.0% | +364.4% | -98.3% | +71.4% | +79.2% | +1,258.1% | -93.7% | -59.5% | +453.3% | -89.2% | +55.6% | +42.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -234.5% | – | – | – | – | -118.6% | – | – | – | – | -473.4% | – | – | -234.1% | – | -117.9% | – | – | -120.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -244.5% | – | – | – | – | -126.6% | – | – | – | – | -336.2% | – | – | -220.1% | – | -116.7% | – | – | -117.3% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.